Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Jun 2007 15:00

ViaLogy PLC05 June 2007 ViaLogy Announces IPv6-capable MicroSPM(TM)for High Definition SurveillanceVideo Processing LONDON, June 5, 2007 -- ViaLogy plc (LSE: VIY), announced today that it hasdeveloped IPv6-capable MicroSPM(TM), compact embedded hardware for highdefinition video processing applications over IP-converged networks. MicroSPM(TM)extends ViaLogy's SPM(TM)software product family by delivering anetwork-centric hardware policy-engine for fully-autonomous incident-based rapiddetection, analysis and response. The MicroSPM(TM)platform addresses threemajor trends within the global surveillance industry: increasing adoption ofnetwork addressable digital video camera and thermal imagers; need for real-timeautonomous processing by moving the policy and the intelligence to the networkedge, and, the accelerated migration to IPv6 addressing standards. MicroSPM(TM)is powered by ViaLogy's proprietary, patented signal processingQuantum Resonance Interferometry ("QRI") technology for detecting weak signalsand image features in high background clutter. QRI delivers video-applicationsin the form of prepackaged user customizable policies in firmware. Initialapplications include: face-extraction in crowds; human, object and vehicledetection and counting, and license plate reading. Immediate verticals includedefense, oil & gas, enterprise safety and security, and, perimeter and bordersurveillance. MicroSPM(TM)enables high speed processing at the video source,only transmitting policy-based exceptions and events to the operator sites. Italso delivers plug-and-play interoperability for IP-enabled video and night-vision devices from different vendors. Today, video surveillance systems are an essential remote monitoring tool forcritical infrastructure, including airports, border crossings, ports, dams,trains and subways; financial and governmental institutions; power grids,utilities and refining facilities. Video is routinely used by businesses formonitoring entrances, walkways, parking lots and warehouses. In banks andretail, surveillance cameras are strategically positioned to monitor and recordthe behavior of customers and tellers. However, the bulk of decision making isperformed by human operators staring at multiple video consoles and manuallycontrolling cameras. Size of this overall video surveillance market is estimatedat over $3 billion for 2007, with sales of security cameras exceeding 6 millionunits and growing at over 30%. According to ViaLogy CTO, Dr. Sandeep Gulati, "Centralized operator-based videoviewing and security decision making is a major choke-point in timely response.Bulk of video is archived and only used for post-incident analysis. MicroSPM'real-time edge processing will significantly expand the actionable informationbandwidth for customers. This is consistent with our focus on broad marketapplications where ViaLogy's QRI signal processing becomes an enabler." ViaLogy President and CEO, Mr. Shah Talukder stated "Customers are facingsignificant challenges in managing a multitude of sensor, video and otherdevices in their networked environments. We see a significant opportunity forscaleable, cost effective and future-proof solutions to manage their global andregional security networks." He added, "We also see MicroSPM(TM)enablingpartners to IPv6-enable their fixed and mobile sensors and network subsystems". Vialogy is in discussions with customers and partners to pilot and deployMicroSPM(TM)within their surveillance infrastructure. For further information please contact: ViaLogyShah Talukder, President & CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.